FDA Drug Safety Communication: Antipsychotic Drug Labels Updated on Use During Pregnancy and Risk of Abnormal Muscle Movements and Withdrawal Symptoms in Newborns - Drugs.com MedNews
Links shared publicly online about this topic.
- 486total visits
FDA Drug Safety Communication: Antipsychotic Drug Labels Updated on Use During Pregnancy and Risk of Abnormal Muscle Movements and Withdrawal Symptoms in Newborns - Drugs.com MedNews
Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary List of Antipsychotic Drugs Safety Anno
View full resource at drugs.com
Tags: Antipsychotic Medication, Muscle, Drug, Pregnancy, FDA, Safety
Most Recently Shared on February 23, 2011 at 12:16 pm By:
FDA Drug Safety Communication: Antipsychotic Drug Labels Updated on Use During Pregnancy and Risk of Abnor... http://bit.ly/fby1Df #drug
Advertisement
